BIOBank completed the acquisition of Neutromedics.

Synopsis

NewAlpha Asset Management and Capital Croissance-backed BIOBank, a French human origin bone bank, completed the acquisition of Neutromedics, a Swiss distributor of orthobiologics and orthopedic implants. Financial terms were not disclosed.

Principals

target

Neutromedics

bidder

New Alpha Asset Management

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

homburger

HQ - Zurich, Switzerland

legal advisors

bidder

200

Deals

£ 194.01 B

Total Value